

Compact for Safe Cosmetics
|
Animal Testing Policy |


| 1 | UVB hazard/exposure score |
| 1 | UVA hazard/exposure score |
| 0 | sunscreen instability |
*Note that the same active ingredient combination may score differently in two different products depending on the concentration of the ingredients and the mixture of inactive ingredients.
Active ingredient UV |
![]() | ||||||||||||||||||||||||||||||||||||
Product total |
| ||||||||||||||||||||||||||||||||||||
| NANO ZINC OXIDE (20-60nm) ( 7.2? %)  |
| ||||||||||||||||||||||||||||||||||||
| NANO TITANIUM DIOXIDE ( 6.4? %)  |
| ||||||||||||||||||||||||||||||||||||
We have had to assume the percentage of the active ingredients in this product. If you own this product and it has the percentages printed on the package, you can help us fill in this missing information.
Note to manufacturers: We have assumed a typical particle size for the mineral(s) in your product based on typical industry use. We welcome specific data from manufacturers if actual particle size is different.
Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
Ingredients in this product are linked to: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Other concerns for ingredients used in this product: Endocrine disruption, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Contamination concerns, Occupational hazards, Biochemical or cellular level changes |
Note from EWG: Unlike many other kinds of personal care products, sunscreen can provide health benefits, protecting against the sun's cancer-causing UV radiation. More than one million cases of skin cancer are diagnosed in the U.S. every year. Health officials recommend wearing sunscreen as one of many important steps to minimize skin cancer risk. (more sun safety tips)
Ingredients from packaging: ACTIVE INGREDIENTS: ZINC OXIDE, TITANIUM DIOXIDE INACTIVE INGREDIENTS: WATER, ETHYLHEXYL PALMITATE, CYCLOPENTASILOXANE, CYCLOHEXASILOXANE, CETYL PEG/PPG-10/1 DIMETHICONE, CETYL DIMETHICONE, MINERAL OIL, WHOLE LEAF ALOE VERA, HYDROGENATED CASTOR OIL, CERESIN, SODIUM CHLORIDE, PHENOXYETHANOL, METHYLPARABEN, PROPYLPARABEN, BUTYLPARABEN, ETHYLPARABEN
Directions from packaging: Adults and children six months of age and over; apply evenly before sun exposure. Squeeze desired amount into palms and rub together to warm product. Massage into skin until product disappears. Reapply after swimming, excessive perspiring or towel drying. When swimming, a white haze may appear on the skin.
Warnings from packaging: For external use only. Avoid eyes. Discontinue if signs of irritation or rash appear. Keep out of reach of children. Use on infants under 6 months only after consulting a physician.
| score | data gap | concerns | |
| NANO TITANIUM DIOXIDE (Active Ingredient) | 2 | 87% | Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards, Biochemical or cellular level changes |
| METHYLPARABEN | 10 | 63% | Violations, restrictions & warnings, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Biochemical or cellular level changes |
| NANO ZINC OXIDE (20-60nm) (Active Ingredient) | 3 | 70% | Violations, restrictions & warnings, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Occupational hazards |
| BUTYLPARABEN | 6 | 79% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Biochemical or cellular level changes |
| CETYL PEG/ PPG-10/ 1 DIMETHICONE | 4 | 76% | Organ system toxicity (non-reproductive), Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE) |
| ETHYLPARABEN | 5 | 80% | Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| PROPYLPARABEN | 5 | 71% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| MINERAL OIL | 2 | 73% | Organ system toxicity (non-reproductive), Occupational hazards |
| PHENOXYETHANOL | 4 | 67% | Violations, restrictions & warnings, Allergies/immunotoxicity, Irritation (skin, eyes, or lungs), Occupational hazards |
| CYCLOPENTASILOXANE | 2 | 79% | Persistence and bioaccumulation |
| CYCLOHEXASILOXANE | 1 | 82% | Persistence and bioaccumulation |
| CERESIN | 0 | 93% | none identified |
| ETHYLHEXYL PALMITATE | 1 | 92% | Irritation (skin, eyes, or lungs) |
| ALOE BARBADENSIS (ALOE VERA) WHOLE LEAF ALOE VERA | 1 | 72% | none identified |
| CETYL DIMETHICONE | 0 | 99% | none identified |
| HYDROGENATED CASTOR OIL | 0 | 93% | none identified |
| SODIUM CHLORIDE | 0 | 0% | innocuous |
| WATER | 0 | 0% | innocuous |
*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more in vitro tests non-mammalian cells show positive mutation results | ALOE BARBADENSIS (ALOE VERA) | |
| One or more animal studies show tumor formation at high doses | MINERAL OIL | |
| One or more in vitro tests non-mammalian cells show positive mutation results | PHENOXYETHANOL | |
| One or more animal studies show tumor formation at moderate doses | CYCLOPENTASILOXANE | |
| One or more in vitro tests on mammalian cells show positive mutation results | NANO TITANIUM DIOXIDE, NANO ZINC OXIDE (20-60nm) | |
| One or more in vitro tests on mammalian cells show positive mutation results | SODIUM CHLORIDE, PROPYLPARABEN, METHYLPARABEN, ETHYLPARABEN, BUTYLPARABEN |
*This table includes all possible developmental/reproductive toxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show developmental effects at high doses | NANO ZINC OXIDE (20-60nm) | |
| One or more animal studies show reproductive effects at high doses | ETHYLPARABEN | |
| One or more animal studies show reproductive effects at moderate doses | ALOE BARBADENSIS (ALOE VERA) | |
| One or more animal studies show any effects at low doses | PROPYLPARABEN | |
| One or more animal studies show any effects at very low doses | BUTYLPARABEN |
*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | CETYL PEG/ PPG-10/ 1 DIMETHICONE, ALOE BARBADENSIS (ALOE VERA) | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Japan - restricted for use in cosmetics (concentration limit) | PHENOXYETHANOL | |
| Violation of government restrictions - Banned or found unsafe for use in cosmetics | METHYLPARABEN | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - any | NANO ZINC OXIDE (20-60nm) |
*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show brain and nervous system effects at high doses | NANO ZINC OXIDE (20-60nm) | |
| One or more animal studies show brain and nervous system effects at moderate doses | PHENOXYETHANOL, METHYLPARABEN, | |
| One or more animal studies show any effects at moderate doses | CYCLOPENTASILOXANE |
*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show endocrine system disruption at high doses | CYCLOHEXASILOXANE | |
| One or more animal studies show endocrine disruption at moderate doses | CYCLOPENTASILOXANE | |
| Human any disruptor - strong evidence | PROPYLPARABEN, METHYLPARABEN, ETHYLPARABEN, BUTYLPARABEN |
*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| respiratory - weight of evidence unknown/unassessed/unreview: published lit review or major tox study | NANO TITANIUM DIOXIDE | |
| Limited evidence of skin and immune system toxicity | PHENOXYETHANOL | |
| Human skin toxicant - strong evidence | PROPYLPARABEN, METHYLPARABEN, BUTYLPARABEN, ETHYLPARABEN |
*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Persistent, bioaccumulative in wildlife | CYCLOHEXASILOXANE, CYCLOPENTASILOXANE, NANO ZINC OXIDE (20-60nm) | |
| Not suspected to be bioaccumulative | NANO TITANIUM DIOXIDE |
*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | CYCLOPENTASILOXANE, CYCLOHEXASILOXANE | |
| One or more animal studies show cardiovascular effects at very low doses | NANO TITANIUM DIOXIDE | |
| Limited evidence of sense organ toxicity | BUTYLPARABEN, CETYL PEG/ PPG-10/ 1 DIMETHICONE, ETHYLPARABEN, PROPYLPARABEN | |
| One or more animal studies show classified as toxic effects at moderate doses (low dose studies may be unavailable for this ingredient) | NANO ZINC OXIDE (20-60nm) | |
| One or more animal studies show gastrointestinal effects at moderate doses (low dose studies may be unavailable for this ingredient) | PHENOXYETHANOL | |
| One or more animal studies show broad systemic effects at high doses (low dose studies may be unavailable for this ingredient) | MINERAL OIL | |
| Known human any toxicant | METHYLPARABEN |
*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Wildlife and environmental toxicity | PROPYLPARABEN, NANO ZINC OXIDE (20-60nm) | |
| Wildlife and environmental toxicity | NANO TITANIUM DIOXIDE |
*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show skin irritation at moderate doses | BUTYLPARABEN, CYCLOPENTASILOXANE, MINERAL OIL, NANO ZINC OXIDE (20-60nm), SODIUM CHLORIDE | |
| One or more animal studies show significant but moderate pulmonary irritation at low doses | NANO TITANIUM DIOXIDE | |
| One or more animal studies show skin irritation at low doses | METHYLPARABEN | |
| Classified as irritant | PHENOXYETHANOL | |
| Human any irritant - strong evidence | products for use around the eyes, on the skin, or may be aerosolized (airborne) | ETHYLHEXYL PALMITATE |
*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Safety assessment was based on related chemical | HYDROGENATED CASTOR OIL, CETYL DIMETHICONE | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | PROPYLPARABEN | |
| Insufficient data to determine safety | NANO ZINC OXIDE (20-60nm) | |
| Missing safety data noted by cosmetic industry review | ALOE BARBADENSIS (ALOE VERA) | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | PHENOXYETHANOL, HYDROGENATED CASTOR OIL, METHYLPARABEN, ETHYLPARABEN | |
| Not assessed for safety in cosmetics by industry panel | CETYL PEG/ PPG-10/ 1 DIMETHICONE, CYCLOHEXASILOXANE, CYCLOPENTASILOXANE, MINERAL OIL, NANO ZINC OXIDE (20-60nm), NANO TITANIUM DIOXIDE | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | BUTYLPARABEN, ETHYLHEXYL PALMITATE, CETYL DIMETHICONE, CERESIN |
*This table includes all possible occupational hazards concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Allowed workplace exposures restricted to moderate doses | MINERAL OIL | |
| Allowed workplace exposures restricted to low doses | NANO TITANIUM DIOXIDE, PHENOXYETHANOL | |
| Allowed workplace exposures restricted to low doses | NANO ZINC OXIDE (20-60nm) |
*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Interferes with gene expresion | BUTYLPARABEN, METHYLPARABEN | |
| One or more animal studies show biochemical changes at very low doses where the human health implications are not yet well understood | NANO TITANIUM DIOXIDE | |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | CYCLOPENTASILOXANE |
No items in basket.
Add this product
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
Find out more about the Campaign for Safe Cosmetics.